—
Price
—
Market Cap
—
P/E Ratio
—
Forward P/E
—
EPS (TTM)
—
Dividend Yield
—
Cash
—
Total Debt
—
Shares Out
Institutional Ownership of BLUEPRINT MEDICINES CORP
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for BLUEPRINT MEDICINES CORP
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| SELL | EXIT | — | — | — | |
| 2025-Q2 | |||||
| SELL | -0.4% | 16.6K | $2M | — | |
| 2025-Q1 | |||||
| BUY | +1.1% | 16.7K | $1M | — | |
| 2024-Q4 | |||||
| BUY | +1.1% | 16.5K | $1M | — | |
| 2024-Q3 | |||||
| BUY | +0.4% | 16.3K | $2M | — | |
| 2024-Q2 | |||||
| SELL | -16.4% | 16.2K | $2M | — | |
| 2024-Q1 | |||||
| BUY | +1.0% | 19.4K | $2M | — | |
| 2023-Q4 | |||||
| SELL | -22.4% | 19.2K | $2M | — | |
| 2023-Q3 | |||||
| BUY | +4.4% | 24.8K | $1M | — | |
| 2023-Q2 | |||||
| BUY | +0.6% | 23.7K | $2M | — | |
| 2023-Q1 | |||||
| BUY | +0.7% | 23.6K | $1M | — | |
| 2022-Q4 | |||||
| BUY | +34.0% | 23.4K | $1M | — | |
| 2022-Q3 | |||||
| BUY | +15.3% | 17.5K | $1M | — | |
| 2022-Q2 | |||||
| BUY | NEW | 15.2K | $766000 | — | |
| 2022-Q1 | |||||
| SELL | EXIT | — | — | — | |
| 2021-Q4 | |||||
| SELL | -27.4% | 11.6K | $1M | — | |
| 2021-Q3 | |||||
| BUY | +34.5% | 15.9K | $2M | — | |
| 2021-Q2 | |||||
| SELL | EXIT | — | — | — | |
| SELL | EXIT | — | — | — | |
| BUY | +3.0% | 11.8K | $1M | — | |
| 2021-Q1 | |||||
| SELL | -21.9% | 213.1K | $21M | — | |
| BUY | NEW | 11.5K | $1M | — | |
| 2020-Q4 | |||||
| BUY | NEW | 2.7M | $304M | — | |
| SELL | -80.9% | 272.7K | $31M | — | |
| 2020-Q3 | |||||
| SELL | -12.2% | 1.4M | $133M | — | |
| 2020-Q2 | |||||
| BUY | +1.8% | 1.6M | $127M | — | |
| 2020-Q1 | |||||
| BUY | +22.5% | 1.6M | $94M | — | |
| 2019-Q4 | |||||
| BUY | +63.0% | 1.3M | $105M | — | |
| 2019-Q3 | |||||
| BUY | +45.5% | 801.6K | $59M | — | |
| 2019-Q2 | |||||
| SELL | -16.3% | 551.0K | $52M | — | |
| 2019-Q1 | |||||
| SELL | -45.1% | 658.7K | $53M | — | |
| 2018-Q4 | |||||
| BUY | +980.4% | 1.2M | $65M | — | |
| 2018-Q3 | |||||
| BUY | NEW | 111.1K | $9M | — | |
Insider Trading for BLUEPRINT MEDICINES CORP
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.